Your Messages Inbox
Your Article Summary
See Latest ArticlesAVI BioPharma Presents Safety Data in Duchenne Muscular Dystrophy at 14th Annual International Congress of the World Muscle Society
AVI BioPharma, 09/15/09
AVI BioPharma, Inc., a developer of RNA–based drugs, announced that full data from its completed Phase 1 clinical trial of its splice skipping oligomer AVI–4658 in patients with Duchenne Muscular Dystrophy was presented at the 14th Annual International Congress of the World Muscle Society in Geneva, Switzerland.
Today in Conferences/Meetings...keeping you current
Receive free subspecialty "5-minute updates" via email
New STEDESA Clinical Data Presented at American Epilepsy Society Annual Meeting in Boston
Sepracor, 12/08/09
Forest Laboratories, Inc. to Host Analyst Meeting to Review the Company's Late-Stage Product Development Pipeline
Forest Laboratories, 12/08/09
Cytokinetics Presents Non-Clinical Data Relating To CK-2017357 At The 5th Cachexia Conference
Cytokinetics, 12/08/09
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Autologous blood therapy for common cold—A randomized, double-blind, placebo-controlled trial
Complementary Therapies in Medicine, 12/08/09
Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial
Archives of Drug Information, 12/08/09
Cytokinetics Presents Non-Clinical Data Relating To CK-2017357 At The 5th Cachexia Conference
Cytokinetics, 12/08/09
Article Search
Sponsor